Literature DB >> 27718058

Mitochondrial Changes in Cancer.

Shubha Gururaja Rao1.   

Abstract

Mitochondrial structural and functional integrity defines the health of a cell by regulating cellular metabolism. Thus, mitochondria play an important role in both cell proliferation and cell death. Cancer cells are metabolically altered compared to normal cells for their ability to survive better and proliferate faster. Resistance to apoptosis is an important characteristic of cancer cells and given the contribution of mitochondria to apoptosis, it is imperative that mitochondria could behave differently in a tumor situation. The other feature associated with cancer cells is the Warburg effect, which engages a shift in metabolism. Although the Warburg effect often occurs in conjunction with dysfunctional mitochondria, the relationship between mitochondria, the Warburg effect, and cancer cell metabolism is not clearly decoded. Other than these changes, several mitochondrial gene mutations occur in cancer cells, mitochondrial biogenesis is affected and mitochondria see structural and functional variations. In cancer pharmacology, targeting mitochondria and mitochondria associated signaling pathways to reduce tumor proliferation is a growing field of interest. This chapter summarizes various changes in mitochondria in relevance to cancer, behavior of mitochondria during tumorigenesis, and the progress on using mitochondria as a therapeutic target for cancer.

Entities:  

Keywords:  Apoptosis; Cancer; Mitochondria; Mitochondrial fission; Mitochondrial fusion; Reactive oxygen species

Mesh:

Substances:

Year:  2017        PMID: 27718058     DOI: 10.1007/164_2016_40

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  5 in total

Review 1.  Tumor metabolic reprogramming in lung cancer progression.

Authors:  Xin Li; Minghui Liu; Hongyu Liu; Jun Chen
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

2.  MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma.

Authors:  Yu Zhang; Hui Li; Hulin Chang; Lixue Du; Jun Hai; Xilin Geng; Xiang Yan
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 3.  Potential Mechanism Underlying the Role of Mitochondria in Breast Cancer Drug Resistance and Its Related Treatment Prospects.

Authors:  Yuefeng Li; Zhian Li
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

4.  Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo.

Authors:  Jie Zhang; Ping-Ping Jia; Qing-Le Liu; Ming-Hua Cong; Yun Gao; Han-Ping Shi; Wei-Nan Yu; Ming-Yong Miao
Journal:  J Lipid Res       Date:  2018-02-05       Impact factor: 5.922

5.  Knockdown of Gastrin Promotes Apoptosis of Gastric Cancer Cells by Decreasing ROS Generation.

Authors:  Yan Liu; Jihai Zhu; Jun Liu; Xueman Ma; Jun Zhao; Zhanhai Su
Journal:  Biomed Res Int       Date:  2021-04-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.